Keynote by

John Lapre

CTO, Elekta

MR-guided radiotherapy: combining two high-tech worlds sounds simple, but is it?

In a true paradigm shift allowing for better and new treatment options for cancer patients, a large collaboration project between Elekta, Philips and UMC Utrecht plus a global clinical consortium aimed to provide a diagnostic quality soft tissue visualization during state-of-the-art radiation delivery. Combining an MR and a linear accelerator (linac) for see-what-you-treat tumor irradiation required collaboration between many disciplines like clinical, software, hardware and integrated systems and different R&D sites. The bumpy road from idea to prototypes to clinical implementation and the many pitfalls and learnings will be presented. Benefits will be shown connected to design choices and clinical implementation.

John Lapre studied nutrition and toxicology in Wageningen. His PhD focused on prevention of colonic cancer. After several leadership positions in different multinationals he joined Nucletron, the leader in brachytherapy (internal radiotherapy) in 2009 as VP R&D. After the acquisition by Elekta he became executive VP brachytherapy and member of Elekta’s executive management team. Since May 2016 he is chief technology officer for Elekta leading the global product management, research and engineering organizations. John is a Dutch native and works out of Elekta’s office in Veenendaal.